Huntington's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been confirmed to carry the genetic change that causes Huntington's disease (HD), or you have a family history of HD along with typical symptoms such as involuntary movements (chorea)
- Your HD is at an early or moderate stage (stages 1, 2, or 3 on a standard HD rating scale)
- You have mild to moderate behavioral symptoms, based on a specific symptom rating tool — none of your symptoms are at the most severe level on that scale (confirm with trial site)
- You have been on stable doses of any medications for at least one month
- You have a caregiver who is willing to be present during treatment sessions and fill out questionnaires
Who may not be able to join:
- You have unstable health conditions
- You have a history of epilepsy
- You have any metal objects in your brain (such as certain implants)
- You have been diagnosed with a major thinking or memory disorder, or dementia
- You have had any thoughts or behaviors related to suicide in the past 3 months, at a certain level of seriousness as measured by a standard assessment tool (confirm with trial site)
- You are currently taking part in another clinical trial
- You are not able to give your own informed consent to participate
- Your caregiver has symptoms related to Alzheimer's disease or Huntington's disease that could affect their ability to help you during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erin Stimming, MD, The University of Texas Health Science Center, Houston
Phone: (713) 500-7033
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility as assessed by the number of participants included and who successfully completed the protocol; Change in acceptability of the treatment as assessed by the tDCS acceptability questionnaire; Change in safety of home-based tDCS treatment as as assessed by the tDCS side effect questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.